{
  "resourceType": "MedicationDispense",
  "id": "meddisp0306",
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative: MedicationDispense\u003c/b\u003e\u003ca name\u003d\"meddisp0306\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource MedicationDispense \u0026quot;meddisp0306\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: in-progress\u003c/p\u003e\u003ch3\u003eMedications\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eReference\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003e\u003ca name\u003d\"med0303\"\u003e \u003c/a\u003e\u003cblockquote\u003e\u003cp/\u003e\u003cp\u003e\u003ca name\u003d\"med0303\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: Alemtuzumab 10mg/ml (Lemtrada) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"http://terminology.hl7.org/4.0.0/CodeSystem-v3-rxNorm.html\"\u003eRxNorm\u003c/a\u003e#1594660)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003cp\u003e\u003cb\u003esubject\u003c/b\u003e: \u003ca href\u003d\"patient-example-a.html\"\u003ePatient/pat1: Donald Duck\u003c/a\u003e \u0026quot;Donald DUCK\u0026quot;\u003c/p\u003e\u003ch3\u003ePerformers\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eActor\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003e\u003ca href\u003d\"practitioner-example-f006-rvdb.html\"\u003ePractitioner/f006\u003c/a\u003e \u0026quot;Rob VAN DEN BERK\u0026quot;\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003cp\u003e\u003cb\u003eauthorizingPrescription\u003c/b\u003e: \u003ca href\u003d\"medicationrequest0317.html\"\u003eMedicationRequest/medrx0317\u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etype\u003c/b\u003e: Daily Fill \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"http://terminology.hl7.org/4.0.0/CodeSystem-v3-ActCode.html\"\u003eActCode\u003c/a\u003e#DF)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003equantity\u003c/b\u003e: 5(unit 415818006 from http://snomed.info/sct)\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: SNOMED CT code 415818006 \u003d \u0027Vial\u0027)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edaysSupply\u003c/b\u003e: 7 Day\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code d \u003d \u0027d\u0027)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ewhenPrepared\u003c/b\u003e: 2015-01-15T10:20:00Z\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edosageInstruction\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esequence\u003c/b\u003e: 1\u003c/p\u003e\u003cp\u003e\u003cb\u003etext\u003c/b\u003e: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/p\u003e\u003cp\u003e\u003cb\u003eadditionalInstruction\u003c/b\u003e: Rapidly increase dose until tolerated \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e, Administer on alternate days \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etiming\u003c/b\u003e: Duration 12weeks, 3 per 1 weeks\u003c/p\u003e\u003cp\u003e\u003cb\u003eroute\u003c/b\u003e: Intravenous route (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#47625008)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003emethod\u003c/b\u003e: Inject - dosing instruction imperative (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#422145002)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edosageInstruction\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esequence\u003c/b\u003e: 2\u003c/p\u003e\u003cp\u003e\u003cb\u003etext\u003c/b\u003e: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/p\u003e\u003cp\u003e\u003cb\u003eadditionalInstruction\u003c/b\u003e: Rapidly increase dose until tolerated \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e, Administer on alternate days \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etiming\u003c/b\u003e: Duration 12weeks, 3 per 1 weeks\u003c/p\u003e\u003cp\u003e\u003cb\u003eroute\u003c/b\u003e: Intravenous route (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#47625008)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003emethod\u003c/b\u003e: Inject - dosing instruction imperative (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#422145002)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edosageInstruction\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esequence\u003c/b\u003e: 3\u003c/p\u003e\u003cp\u003e\u003cb\u003etext\u003c/b\u003e: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/p\u003e\u003cp\u003e\u003cb\u003eadditionalInstruction\u003c/b\u003e: Rapidly increase dose until tolerated \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e, Administer on alternate days \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etiming\u003c/b\u003e: Duration 12weeks, 3 per 1 weeks\u003c/p\u003e\u003cp\u003e\u003cb\u003eroute\u003c/b\u003e: Intravenous route (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#47625008)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003emethod\u003c/b\u003e: Inject - dosing instruction imperative (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#422145002)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/div\u003e"
  },
  "contained": [
    {
      "resourceType": "Medication",
      "id": "med0303",
      "code": {
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1594660",
            "display": "Alemtuzumab 10mg/ml (Lemtrada)"
          }
        ]
      }
    }
  ],
  "status": "in-progress",
  "medication": {
    "reference": {
      "reference": "#med0303",
      "display": "Alemtuzumab 10mg/ml (Lemtrada)"
    }
  },
  "subject": {
    "reference": "Patient/pat1",
    "display": "Donald Duck"
  },
  "performer": [
    {
      "actor": {
        "reference": "Practitioner/f006"
      }
    }
  ],
  "authorizingPrescription": [
    {
      "reference": "MedicationRequest/medrx0317"
    }
  ],
  "type": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "code": "DF",
        "display": "Daily Fill"
      }
    ]
  },
  "quantity": {
    "value": 5,
    "system": "http://snomed.info/sct",
    "code": "415818006"
  },
  "daysSupply": {
    "value": 7,
    "unit": "Day",
    "system": "http://unitsofmeasure.org",
    "code": "d"
  },
  "whenPrepared": "2015-01-15T10:20:00Z",
  "dosageInstruction": [
    {
      "sequence": 1,
      "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
      "additionalInstruction": [
        {
          "text": "Rapidly increase dose until tolerated"
        },
        {
          "text": "Administer on alternate days"
        }
      ],
      "timing": {
        "repeat": {
          "duration": 12,
          "durationUnit": "wk",
          "frequency": 3,
          "period": 1,
          "periodUnit": "wk"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "47625008",
            "display": "Intravenous route (qualifier value)"
          }
        ]
      },
      "method": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "422145002",
            "display": "Inject - dosing instruction imperative (qualifier value)"
          }
        ]
      },
      "doseAndRate": [
        {
          "type": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type",
                "code": "calculated",
                "display": "Calculated"
              }
            ]
          },
          "doseQuantity": {
            "value": 3,
            "unit": "mg",
            "system": "http://unitsofmeasure.org",
            "code": "mg"
          }
        }
      ]
    },
    {
      "sequence": 2,
      "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
      "additionalInstruction": [
        {
          "text": "Rapidly increase dose until tolerated"
        },
        {
          "text": "Administer on alternate days"
        }
      ],
      "timing": {
        "repeat": {
          "duration": 12,
          "durationUnit": "wk",
          "frequency": 3,
          "period": 1,
          "periodUnit": "wk"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "47625008",
            "display": "Intravenous route (qualifier value)"
          }
        ]
      },
      "method": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "422145002",
            "display": "Inject - dosing instruction imperative (qualifier value)"
          }
        ]
      },
      "doseAndRate": [
        {
          "type": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type",
                "code": "calculated",
                "display": "Calculated"
              }
            ]
          },
          "doseQuantity": {
            "value": 10,
            "unit": "mg",
            "system": "http://unitsofmeasure.org",
            "code": "mg"
          }
        }
      ]
    },
    {
      "sequence": 3,
      "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
      "additionalInstruction": [
        {
          "text": "Rapidly increase dose until tolerated"
        },
        {
          "text": "Administer on alternate days"
        }
      ],
      "timing": {
        "repeat": {
          "duration": 12,
          "durationUnit": "wk",
          "frequency": 3,
          "period": 1,
          "periodUnit": "wk"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "47625008",
            "display": "Intravenous route (qualifier value)"
          }
        ]
      },
      "method": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "422145002",
            "display": "Inject - dosing instruction imperative (qualifier value)"
          }
        ]
      },
      "doseAndRate": [
        {
          "type": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type",
                "code": "calculated",
                "display": "Calculated"
              }
            ]
          },
          "doseQuantity": {
            "value": 30,
            "unit": "mg",
            "system": "http://unitsofmeasure.org",
            "code": "mg"
          }
        }
      ]
    }
  ],
  "meta": {
    "tag": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code": "HTEST",
        "display": "test health data"
      }
    ]
  }
}